Rank | Gene Set | Z-score |
---|---|---|
1 | hemidesmosome assembly (GO:0031581) | 5.77158200 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.54143181 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.54143181 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.69249726 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.56735311 |
6 | leukocyte aggregation (GO:0070486) | 4.51871772 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.49973728 |
8 | ribosomal small subunit biogenesis (GO:0042274) | 4.38372468 |
9 | protein maturation by protein folding (GO:0022417) | 4.16717402 |
10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.15645562 |
11 | maturation of SSU-rRNA (GO:0030490) | 4.08886462 |
12 | neutrophil activation involved in immune response (GO:0002283) | 4.00864428 |
13 | T cell migration (GO:0072678) | 3.99471479 |
14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.93034524 |
15 | negative regulation of cell killing (GO:0031342) | 3.93034524 |
16 | proteasome assembly (GO:0043248) | 3.91770467 |
17 | establishment of integrated proviral latency (GO:0075713) | 3.76224023 |
18 | negative T cell selection (GO:0043383) | 3.76112733 |
19 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.75904024 |
20 | mast cell activation (GO:0045576) | 3.75398540 |
21 | ribosomal large subunit biogenesis (GO:0042273) | 3.72428852 |
22 | negative thymic T cell selection (GO:0045060) | 3.69972268 |
23 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.67465316 |
24 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.63236223 |
25 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.61814560 |
26 | positive thymic T cell selection (GO:0045059) | 3.57435205 |
27 | protein retention in ER lumen (GO:0006621) | 3.54526316 |
28 | formation of translation preinitiation complex (GO:0001731) | 3.51554349 |
29 | respiratory burst (GO:0045730) | 3.50705576 |
30 | mitotic chromosome condensation (GO:0007076) | 3.50536941 |
31 | chaperone-mediated protein transport (GO:0072321) | 3.50158890 |
32 | membrane raft organization (GO:0031579) | 3.47848061 |
33 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.45854567 |
34 | DNA unwinding involved in DNA replication (GO:0006268) | 3.45490732 |
35 | cotranslational protein targeting to membrane (GO:0006613) | 3.41684330 |
36 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.41590646 |
37 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.41299273 |
38 | protein targeting to ER (GO:0045047) | 3.39959038 |
39 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.38128272 |
40 | ribosomal small subunit assembly (GO:0000028) | 3.36006264 |
41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.35015546 |
42 | translational termination (GO:0006415) | 3.34422253 |
43 | DNA strand elongation (GO:0022616) | 3.33024383 |
44 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.32365459 |
45 | chromatin remodeling at centromere (GO:0031055) | 3.29706192 |
46 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.27815895 |
47 | thymic T cell selection (GO:0045061) | 3.27785702 |
48 | interferon-gamma production (GO:0032609) | 3.26691558 |
49 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.25537030 |
50 | CENP-A containing nucleosome assembly (GO:0034080) | 3.25301400 |
51 | protein localization to endoplasmic reticulum (GO:0070972) | 3.24407309 |
52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.21976504 |
53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.21127809 |
54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.21127809 |
55 | modulation by symbiont of host immune response (GO:0052553) | 3.21127809 |
56 | positive regulation by symbiont of host defense response (GO:0052509) | 3.21127809 |
57 | modulation by symbiont of host defense response (GO:0052031) | 3.21127809 |
58 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.21127809 |
59 | mitotic metaphase plate congression (GO:0007080) | 3.21110691 |
60 | leukocyte cell-cell adhesion (GO:0007159) | 3.19352058 |
61 | ribosome assembly (GO:0042255) | 3.18668577 |
62 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.18327470 |
63 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.17226923 |
64 | protein localization to chromosome, centromeric region (GO:0071459) | 3.16774318 |
65 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.16463206 |
66 | central nervous system myelination (GO:0022010) | 3.15653885 |
67 | axon ensheathment in central nervous system (GO:0032291) | 3.15653885 |
68 | sequestering of actin monomers (GO:0042989) | 3.14352797 |
69 | immunoglobulin mediated immune response (GO:0016064) | 3.10466602 |
70 | mitotic nuclear envelope reassembly (GO:0007084) | 3.10335202 |
71 | nuclear envelope reassembly (GO:0031468) | 3.10335202 |
72 | activated T cell proliferation (GO:0050798) | 3.10295463 |
73 | protein complex localization (GO:0031503) | 3.10150731 |
74 | protein localization to kinetochore (GO:0034501) | 3.10104377 |
75 | establishment of viral latency (GO:0019043) | 3.09239617 |
76 | negative regulation of ligase activity (GO:0051352) | 3.09225583 |
77 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.09225583 |
78 | purine nucleobase biosynthetic process (GO:0009113) | 3.08122370 |
79 | regulation of gamma-delta T cell activation (GO:0046643) | 3.06222006 |
80 | regulation of T cell tolerance induction (GO:0002664) | 3.05765527 |
81 | desmosome organization (GO:0002934) | 3.05021823 |
82 | tolerance induction (GO:0002507) | 3.04137426 |
83 | de novo protein folding (GO:0006458) | 3.03116055 |
84 | neutrophil activation (GO:0042119) | 3.03063984 |
85 | Golgi transport vesicle coating (GO:0048200) | 3.01378964 |
86 | COPI coating of Golgi vesicle (GO:0048205) | 3.01378964 |
87 | positive regulation of lamellipodium assembly (GO:0010592) | 3.00786332 |
88 | heterotypic cell-cell adhesion (GO:0034113) | 2.99570053 |
89 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.99063019 |
90 | ATP synthesis coupled proton transport (GO:0015986) | 2.98393053 |
91 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.98393053 |
92 | granulocyte activation (GO:0036230) | 2.97153226 |
93 | cellular protein complex localization (GO:0034629) | 2.96201772 |
94 | myeloid cell activation involved in immune response (GO:0002275) | 2.95744204 |
95 | cellular response to type I interferon (GO:0071357) | 2.95206518 |
96 | type I interferon signaling pathway (GO:0060337) | 2.95206518 |
97 | response to type I interferon (GO:0034340) | 2.95191186 |
98 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.93736473 |
99 | translational initiation (GO:0006413) | 2.93068139 |
100 | heterochromatin organization (GO:0070828) | 2.93055665 |
101 | translation (GO:0006412) | 2.93014562 |
102 | DNA replication checkpoint (GO:0000076) | 2.92476844 |
103 | T cell receptor signaling pathway (GO:0050852) | 2.91638618 |
104 | positive regulation of isotype switching (GO:0045830) | 2.90567051 |
105 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.90305828 |
106 | ribosome biogenesis (GO:0042254) | 2.89956037 |
107 | de novo posttranslational protein folding (GO:0051084) | 2.89279847 |
108 | tRNA aminoacylation for protein translation (GO:0006418) | 2.85189592 |
109 | response to interleukin-15 (GO:0070672) | 2.85148849 |
110 | T cell selection (GO:0045058) | 2.84663238 |
111 | viral life cycle (GO:0019058) | 2.83528662 |
112 | mast cell degranulation (GO:0043303) | 2.83200903 |
113 | mast cell activation involved in immune response (GO:0002279) | 2.83200903 |
114 | T cell costimulation (GO:0031295) | 2.82558716 |
115 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.82139380 |
116 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.81994351 |
117 | cellular extravasation (GO:0045123) | 2.81776481 |
118 | translational elongation (GO:0006414) | 2.81167645 |
119 | positive regulation of tolerance induction (GO:0002645) | 2.80819812 |
120 | lymphocyte costimulation (GO:0031294) | 2.78082853 |
121 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.77581194 |
122 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.77173838 |
123 | protein localization to endosome (GO:0036010) | 2.75615018 |
124 | positive regulation of macrophage differentiation (GO:0045651) | 2.75307475 |
125 | regulation of mitochondrial translation (GO:0070129) | 2.74959418 |
126 | leukocyte degranulation (GO:0043299) | 2.74329832 |
127 | amino acid activation (GO:0043038) | 2.73470760 |
128 | tRNA aminoacylation (GO:0043039) | 2.73470760 |
129 | nuclear pore complex assembly (GO:0051292) | 2.73204443 |
130 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.73063537 |
131 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.72909876 |
132 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.72710839 |
133 | nucleobase biosynthetic process (GO:0046112) | 2.72436502 |
134 | ncRNA 3-end processing (GO:0043628) | 2.72090774 |
135 | cell adhesion mediated by integrin (GO:0033627) | 2.71992963 |
136 | IMP biosynthetic process (GO:0006188) | 2.71609276 |
137 | regulation of translational fidelity (GO:0006450) | 2.71470341 |
138 | regulation of translational termination (GO:0006449) | 2.71423096 |
139 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.70166667 |
140 | oxidative phosphorylation (GO:0006119) | 2.68239748 |
141 | positive T cell selection (GO:0043368) | 2.68140071 |
142 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.68115291 |
143 | cellular protein complex disassembly (GO:0043624) | 2.67899852 |
144 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.66695098 |
145 | protein targeting to mitochondrion (GO:0006626) | 2.66575035 |
146 | lymphocyte migration (GO:0072676) | 2.66264009 |
147 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.65799883 |
148 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.64745494 |
149 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.64735617 |
150 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.63989459 |
151 | rRNA processing (GO:0006364) | 2.62470352 |
152 | localization within membrane (GO:0051668) | 2.61602118 |
153 | B cell receptor signaling pathway (GO:0050853) | 2.61543944 |
154 | regulation of tolerance induction (GO:0002643) | 2.61394619 |
155 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61195239 |
156 | positive regulation of antigen processing and presentation (GO:0002579) | 2.58601432 |
157 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.58404547 |
158 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58387974 |
159 | regulation of hypersensitivity (GO:0002883) | 2.58337623 |
160 | histone arginine methylation (GO:0034969) | 2.57475235 |
161 | metaphase plate congression (GO:0051310) | 2.57387599 |
162 | cellular response to interleukin-15 (GO:0071350) | 2.57150112 |
163 | nuclear pore organization (GO:0006999) | 2.56752423 |
164 | protein localization to mitochondrion (GO:0070585) | 2.56190579 |
165 | mitotic sister chromatid segregation (GO:0000070) | 2.55879306 |
166 | negative regulation of RNA splicing (GO:0033119) | 2.54995241 |
167 | DNA replication-independent nucleosome organization (GO:0034724) | 2.54621767 |
168 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.54621767 |
169 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.54037098 |
170 | positive regulation of B cell differentiation (GO:0045579) | 2.53858860 |
171 | natural killer cell differentiation (GO:0001779) | 2.53598699 |
172 | positive regulation of interleukin-2 production (GO:0032743) | 2.53485284 |
173 | telomere maintenance via recombination (GO:0000722) | 2.53295283 |
174 | cellular component biogenesis (GO:0044085) | 2.53203204 |
175 | pore complex assembly (GO:0046931) | 2.51802479 |
176 | histone exchange (GO:0043486) | 2.51691545 |
177 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.50646497 |
178 | natural killer cell activation (GO:0030101) | 2.50271250 |
179 | protein targeting to membrane (GO:0006612) | 2.49814421 |
180 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.49323076 |
181 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.49120366 |
182 | L-serine metabolic process (GO:0006563) | 2.49011966 |
183 | myeloid cell homeostasis (GO:0002262) | 2.48685446 |
184 | myeloid dendritic cell activation (GO:0001773) | 2.48344864 |
185 | protein neddylation (GO:0045116) | 2.48208550 |
186 | regulation of B cell differentiation (GO:0045577) | 2.47902221 |
187 | response to muramyl dipeptide (GO:0032495) | 2.47387849 |
188 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.46731049 |
189 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.43457011 |
190 | positive regulation of DNA recombination (GO:0045911) | 2.43274032 |
191 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.42292419 |
192 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.41491447 |
193 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.41491447 |
194 | myeloid leukocyte activation (GO:0002274) | 2.41447917 |
195 | positive regulation of interferon-alpha production (GO:0032727) | 2.40683217 |
196 | viral transcription (GO:0019083) | 2.40495847 |
197 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.39378476 |
198 | positive regulation of B cell mediated immunity (GO:0002714) | 2.39378476 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.22566194 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.48577196 |
3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.48277961 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.20958415 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.46318734 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.28252062 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.27431830 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.14732045 |
9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.04015674 |
10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.99201684 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.97650997 |
12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.95659360 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.93419423 |
14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90786759 |
15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.89254245 |
16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.88982909 |
17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88026960 |
18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83602722 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82643850 |
20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.82377044 |
21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.82123421 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.76598746 |
23 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.74914958 |
24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.71099337 |
25 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.69985295 |
26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.62284383 |
27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.59241039 |
28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.55522956 |
29 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.49200543 |
30 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.48858802 |
31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.46125411 |
32 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.45043721 |
33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.40980349 |
34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.40730756 |
35 | MAF_26560356_Chip-Seq_TH1_Human | 2.40209106 |
36 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.32508895 |
37 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.30901683 |
38 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.23643280 |
39 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.20068042 |
40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.18893145 |
41 | MYB_26560356_Chip-Seq_TH1_Human | 2.17742319 |
42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.14612871 |
43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.11267404 |
44 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.10634013 |
45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.10233880 |
46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.09619167 |
47 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.09260045 |
48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06974162 |
49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.03320737 |
50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02570806 |
51 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.01818636 |
52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00843439 |
53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98049831 |
54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97164627 |
55 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.96988103 |
56 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.96167177 |
57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.94772136 |
58 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91171601 |
59 | MYC_22102868_ChIP-Seq_BL_Human | 1.86595965 |
60 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84909600 |
61 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.82398499 |
62 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.80422811 |
63 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.78273597 |
64 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.73345324 |
65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.72517262 |
66 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.71249154 |
67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70762732 |
68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70521136 |
69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.70314758 |
70 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.66928579 |
71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66513767 |
72 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65053305 |
73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64430819 |
74 | MAF_26560356_Chip-Seq_TH2_Human | 1.63950218 |
75 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.62052686 |
76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61880056 |
77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59848357 |
78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57300179 |
79 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.52186042 |
80 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.50151559 |
81 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49096827 |
82 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.48535500 |
83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46497162 |
84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45914018 |
85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45905378 |
86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45036015 |
87 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44768151 |
88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43073307 |
89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.43015064 |
90 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42781828 |
91 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.42226378 |
92 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.41918709 |
93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41757331 |
94 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.39778542 |
95 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.37357283 |
96 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.35944392 |
97 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35767297 |
98 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34580919 |
99 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.33749387 |
100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32662589 |
101 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31495468 |
102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31250442 |
103 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29617527 |
104 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.27671605 |
105 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27289473 |
106 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.25978264 |
107 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.23690809 |
108 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23191312 |
109 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22166229 |
110 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20373849 |
111 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.18680701 |
112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18377059 |
113 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.17115769 |
114 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13938375 |
115 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13631794 |
116 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.12562412 |
117 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12201265 |
118 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11908693 |
119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11750602 |
120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11412819 |
121 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.11069529 |
122 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10864262 |
123 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10292457 |
124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10115688 |
125 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.09993535 |
126 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09565260 |
127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09216827 |
128 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.08172961 |
129 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08069677 |
130 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06902669 |
131 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06796333 |
132 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06198301 |
133 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.06105059 |
134 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05845080 |
135 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.05476368 |
136 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05336375 |
137 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04918436 |
138 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.04012316 |
139 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.03837477 |
140 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03825144 |
141 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03602047 |
142 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03449511 |
143 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03427501 |
144 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02569667 |
145 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02235513 |
146 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01508970 |
147 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01451234 |
148 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00244290 |
149 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.99831340 |
150 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.98761928 |
151 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97767018 |
152 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97232468 |
153 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97076827 |
154 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.96271660 |
155 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96143589 |
156 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94802681 |
157 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94670267 |
158 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.94476676 |
159 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94057555 |
160 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93983553 |
161 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93960292 |
162 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.93898712 |
163 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92808083 |
164 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92636217 |
165 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91802096 |
166 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91741052 |
167 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91706563 |
168 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.91643620 |
169 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91265935 |
170 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90815533 |
171 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87490398 |
172 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.84975686 |
173 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84683065 |
174 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84392534 |
175 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.84282686 |
176 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83475410 |
177 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83374602 |
178 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83374602 |
179 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83034867 |
180 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82683878 |
181 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82322449 |
182 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.79776047 |
183 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78975204 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000579_abnormal_nail_morphology | 4.47822007 |
2 | MP0009379_abnormal_foot_pigmentation | 3.45774297 |
3 | MP0003941_abnormal_skin_development | 3.37457482 |
4 | MP0004957_abnormal_blastocyst_morpholog | 3.35193042 |
5 | MP0001835_abnormal_antigen_presentation | 2.94362309 |
6 | MP0006082_CNS_inflammation | 2.86125846 |
7 | MP0005671_abnormal_response_to | 2.84826285 |
8 | MP0003436_decreased_susceptibility_to | 2.80511367 |
9 | MP0005000_abnormal_immune_tolerance | 2.78952706 |
10 | MP0003763_abnormal_thymus_physiology | 2.78537205 |
11 | MP0008932_abnormal_embryonic_tissue | 2.69312253 |
12 | MP0004272_abnormal_basement_membrane | 2.68514449 |
13 | MP0002877_abnormal_melanocyte_morpholog | 2.65421223 |
14 | MP0000685_abnormal_immune_system | 2.61861889 |
15 | MP0003303_peritoneal_inflammation | 2.60382121 |
16 | MP0003724_increased_susceptibility_to | 2.58149185 |
17 | MP0010030_abnormal_orbit_morphology | 2.50080449 |
18 | MP0009785_altered_susceptibility_to | 2.46116601 |
19 | MP0005058_abnormal_lysosome_morphology | 2.45732652 |
20 | MP0003111_abnormal_nucleus_morphology | 2.43951819 |
21 | MP0002723_abnormal_immune_serum | 2.38639431 |
22 | MP0001800_abnormal_humoral_immune | 2.37045835 |
23 | MP0005025_abnormal_response_to | 2.35428303 |
24 | MP0004947_skin_inflammation | 2.35258216 |
25 | MP0001790_abnormal_immune_system | 2.34002705 |
26 | MP0005387_immune_system_phenotype | 2.34002705 |
27 | MP0002452_abnormal_antigen_presenting | 2.33563535 |
28 | MP0002419_abnormal_innate_immunity | 2.30605491 |
29 | MP0008438_abnormal_cutaneous_collagen | 2.29886258 |
30 | MP0003705_abnormal_hypodermis_morpholog | 2.28047397 |
31 | MP0002420_abnormal_adaptive_immunity | 2.27942778 |
32 | MP0002148_abnormal_hypersensitivity_rea | 2.27144759 |
33 | MP0001819_abnormal_immune_cell | 2.25941187 |
34 | MP0009333_abnormal_splenocyte_physiolog | 2.19621348 |
35 | MP0002166_altered_tumor_susceptibility | 2.18608133 |
36 | MP0010094_abnormal_chromosome_stability | 2.16627283 |
37 | MP0003315_abnormal_perineum_morphology | 2.16491519 |
38 | MP0005257_abnormal_intraocular_pressure | 2.14022679 |
39 | MP0000920_abnormal_myelination | 2.06953084 |
40 | MP0003186_abnormal_redox_activity | 2.05624903 |
41 | MP0002405_respiratory_system_inflammati | 1.93926187 |
42 | MP0002006_tumorigenesis | 1.93209990 |
43 | MP0001849_ear_inflammation | 1.91308224 |
44 | MP0004782_abnormal_surfactant_physiolog | 1.91088188 |
45 | MP0002398_abnormal_bone_marrow | 1.90351042 |
46 | MP0004858_abnormal_nervous_system | 1.88193356 |
47 | MP0001533_abnormal_skeleton_physiology | 1.84351835 |
48 | MP0001851_eye_inflammation | 1.80618437 |
49 | MP0000716_abnormal_immune_system | 1.79776702 |
50 | MP0003077_abnormal_cell_cycle | 1.79409369 |
51 | MP0005464_abnormal_platelet_physiology | 1.77522856 |
52 | MP0000762_abnormal_tongue_morphology | 1.75651046 |
53 | MP0003300_gastrointestinal_ulcer | 1.74917820 |
54 | MP0000467_abnormal_esophagus_morphology | 1.69466163 |
55 | MP0009053_abnormal_anal_canal | 1.68943707 |
56 | MP0008789_abnormal_olfactory_epithelium | 1.65191833 |
57 | MP0000465_gastrointestinal_hemorrhage | 1.63613487 |
58 | MP0003448_altered_tumor_morphology | 1.62955732 |
59 | MP0000537_abnormal_urethra_morphology | 1.60627547 |
60 | MP0010352_gastrointestinal_tract_polyps | 1.58857776 |
61 | MP0002933_joint_inflammation | 1.57344140 |
62 | MP0001188_hyperpigmentation | 1.56752142 |
63 | MP0002722_abnormal_immune_system | 1.54630345 |
64 | MP0002396_abnormal_hematopoietic_system | 1.53031128 |
65 | MP0000689_abnormal_spleen_morphology | 1.51278501 |
66 | MP0000383_abnormal_hair_follicle | 1.48896773 |
67 | MP0002429_abnormal_blood_cell | 1.45725716 |
68 | MP0000858_altered_metastatic_potential | 1.45326280 |
69 | MP0001845_abnormal_inflammatory_respons | 1.45032704 |
70 | MP0004381_abnormal_hair_follicle | 1.44629161 |
71 | MP0010155_abnormal_intestine_physiology | 1.44580361 |
72 | MP0003453_abnormal_keratinocyte_physiol | 1.41943962 |
73 | MP0004185_abnormal_adipocyte_glucose | 1.39153535 |
74 | MP0005410_abnormal_fertilization | 1.38931017 |
75 | MP0005499_abnormal_olfactory_system | 1.38853159 |
76 | MP0005394_taste/olfaction_phenotype | 1.38853159 |
77 | MP0008007_abnormal_cellular_replicative | 1.38241238 |
78 | MP0001730_embryonic_growth_arrest | 1.37399241 |
79 | MP0000703_abnormal_thymus_morphology | 1.36860707 |
80 | MP0000350_abnormal_cell_proliferation | 1.36824704 |
81 | MP0010678_abnormal_skin_adnexa | 1.33786098 |
82 | MP0009278_abnormal_bone_marrow | 1.33512150 |
83 | MP0003806_abnormal_nucleotide_metabolis | 1.33491550 |
84 | MP0001873_stomach_inflammation | 1.33242345 |
85 | MP0002098_abnormal_vibrissa_morphology | 1.32748782 |
86 | MP0004510_myositis | 1.30631604 |
87 | MP0008260_abnormal_autophagy | 1.29067602 |
88 | MP0002998_abnormal_bone_remodeling | 1.25144493 |
89 | MP0002796_impaired_skin_barrier | 1.23482970 |
90 | MP0005623_abnormal_meninges_morphology | 1.23206175 |
91 | MP0008058_abnormal_DNA_repair | 1.22636932 |
92 | MP0002234_abnormal_pharynx_morphology | 1.20692938 |
93 | MP0003566_abnormal_cell_adhesion | 1.18933610 |
94 | MP0000566_synostosis | 1.17759605 |
95 | MP0010307_abnormal_tumor_latency | 1.17442748 |
96 | MP0001545_abnormal_hematopoietic_system | 1.16604730 |
97 | MP0005397_hematopoietic_system_phenotyp | 1.16604730 |
98 | MP0000604_amyloidosis | 1.11771720 |
99 | MP0001881_abnormal_mammary_gland | 1.11293185 |
100 | MP0003950_abnormal_plasma_membrane | 1.11051143 |
101 | MP0001672_abnormal_embryogenesis/_devel | 1.10296371 |
102 | MP0005380_embryogenesis_phenotype | 1.10296371 |
103 | MP0003866_abnormal_defecation | 1.09119802 |
104 | MP0000678_abnormal_parathyroid_gland | 1.08638908 |
105 | MP0001216_abnormal_epidermal_layer | 1.08201487 |
106 | MP0003172_abnormal_lysosome_physiology | 1.07364104 |
107 | MP0005197_abnormal_uvea_morphology | 1.06218936 |
108 | MP0002697_abnormal_eye_size | 1.05758503 |
109 | MP0003786_premature_aging | 1.05220464 |
110 | MP0005023_abnormal_wound_healing | 1.03966430 |
111 | MP0003123_paternal_imprinting | 1.03768574 |
112 | MP0004264_abnormal_extraembryonic_tissu | 1.03645665 |
113 | MP0001542_abnormal_bone_strength | 1.03035219 |
114 | MP0002111_abnormal_tail_morphology | 1.02467062 |
115 | MP0000627_abnormal_mammary_gland | 1.02304116 |
116 | MP0000358_abnormal_cell_content/ | 1.01240666 |
117 | MP0002735_abnormal_chemical_nociception | 1.00823622 |
118 | MP0003385_abnormal_body_wall | 1.00135195 |
119 | MP0001853_heart_inflammation | 1.00129027 |
120 | MP0002080_prenatal_lethality | 0.99807692 |
121 | MP0000490_abnormal_crypts_of | 0.98999033 |
122 | MP0004233_abnormal_muscle_weight | 0.98830147 |
123 | MP0004808_abnormal_hematopoietic_stem | 0.98346513 |
124 | MP0002254_reproductive_system_inflammat | 0.97767713 |
125 | MP0000343_altered_response_to | 0.96715638 |
126 | MP0005275_abnormal_skin_tensile | 0.96029803 |
127 | MP0003718_maternal_effect | 0.95025941 |
128 | MP0000372_irregular_coat_pigmentation | 0.94828842 |
129 | MP0001299_abnormal_eye_distance/ | 0.94126552 |
130 | MP0002009_preneoplasia | 0.93706715 |
131 | MP0008469_abnormal_protein_level | 0.93021803 |
132 | MP0005501_abnormal_skin_physiology | 0.93014629 |
133 | MP0005390_skeleton_phenotype | 0.92136336 |
134 | MP0003984_embryonic_growth_retardation | 0.91408386 |
135 | MP0009840_abnormal_foam_cell | 0.90300857 |
136 | MP0001697_abnormal_embryo_size | 0.90267261 |
137 | MP0005310_abnormal_salivary_gland | 0.89796948 |
138 | MP0002085_abnormal_embryonic_tissue | 0.89694321 |
139 | MP0003690_abnormal_glial_cell | 0.88405659 |
140 | MP0006054_spinal_hemorrhage | 0.87860586 |
141 | MP0010771_integument_phenotype | 0.86708285 |
142 | MP0002088_abnormal_embryonic_growth/wei | 0.85440030 |
143 | MP0005174_abnormal_tail_pigmentation | 0.84026965 |
144 | MP0002019_abnormal_tumor_incidence | 0.83791189 |
145 | MP0000377_abnormal_hair_follicle | 0.83494693 |
146 | MP0003937_abnormal_limbs/digits/tail_de | 0.82336500 |
147 | MP0002084_abnormal_developmental_patter | 0.81229298 |
148 | MP0010368_abnormal_lymphatic_system | 0.80241533 |
149 | MP0002233_abnormal_nose_morphology | 0.79767572 |
150 | MP0003755_abnormal_palate_morphology | 0.79508042 |
151 | MP0001727_abnormal_embryo_implantation | 0.79438145 |
152 | MP0000313_abnormal_cell_death | 0.79428503 |
153 | MP0000647_abnormal_sebaceous_gland | 0.79311902 |
154 | MP0003075_altered_response_to | 0.79082087 |
155 | MP0003656_abnormal_erythrocyte_physiolo | 0.78447880 |
156 | MP0005193_abnormal_anterior_eye | 0.78071836 |
157 | MP0000049_abnormal_middle_ear | 0.77291016 |
158 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76816058 |
159 | MP0003045_fibrosis | 0.75781546 |
160 | MP0009384_cardiac_valve_regurgitation | 0.73997452 |
161 | MP0003191_abnormal_cellular_cholesterol | 0.72751895 |
162 | MP0009697_abnormal_copulation | 0.72445010 |
163 | MP0003329_amyloid_beta_deposits | 0.72201093 |
164 | MP0003795_abnormal_bone_structure | 0.70459239 |
165 | MP0003890_abnormal_embryonic-extraembry | 0.70409779 |
166 | MP0001191_abnormal_skin_condition | 0.70188913 |
167 | MP0004147_increased_porphyrin_level | 0.69308793 |
168 | MP0001243_abnormal_dermal_layer | 0.68924285 |
169 | MP0010234_abnormal_vibrissa_follicle | 0.68379772 |
170 | MP0003091_abnormal_cell_migration | 0.66958583 |
171 | MP0002060_abnormal_skin_morphology | 0.65780696 |
172 | MP0009931_abnormal_skin_appearance | 0.65724952 |
173 | MP0005166_decreased_susceptibility_to | 0.65708620 |
174 | MP0003693_abnormal_embryo_hatching | 0.64102281 |
175 | MP0001958_emphysema | 0.63733597 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fragile nails (HP:0001808) | 5.16228435 |
2 | Eczematoid dermatitis (HP:0000976) | 5.01796799 |
3 | Chronic otitis media (HP:0000389) | 4.84547279 |
4 | Onycholysis (HP:0001806) | 4.79799039 |
5 | Recurrent abscess formation (HP:0002722) | 4.63931153 |
6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.54531336 |
7 | T lymphocytopenia (HP:0005403) | 4.31450009 |
8 | Abnormality of T cell number (HP:0011839) | 4.13915370 |
9 | Atrophic scars (HP:0001075) | 3.97095918 |
10 | Recurrent bacterial skin infections (HP:0005406) | 3.96089450 |
11 | Stomatitis (HP:0010280) | 3.95914446 |
12 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.86131021 |
13 | Selective tooth agenesis (HP:0001592) | 3.85139850 |
14 | Abnormality of nail color (HP:0100643) | 3.83354034 |
15 | Abnormality of macrophages (HP:0004311) | 3.74954189 |
16 | Milia (HP:0001056) | 3.67760964 |
17 | Plantar hyperkeratosis (HP:0007556) | 3.65594583 |
18 | Nasal polyposis (HP:0100582) | 3.59754465 |
19 | Recurrent bronchitis (HP:0002837) | 3.50069034 |
20 | Reticulocytopenia (HP:0001896) | 3.47972231 |
21 | Increased cerebral lipofuscin (HP:0011813) | 3.35663941 |
22 | Sparse eyelashes (HP:0000653) | 3.35205433 |
23 | Cellulitis (HP:0100658) | 3.29445510 |
24 | Peripheral hypomyelination (HP:0007182) | 3.28791172 |
25 | Abnormality of the nasal mucosa (HP:0000433) | 3.27467724 |
26 | Recurrent fungal infections (HP:0002841) | 3.24810391 |
27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.21141592 |
28 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.14639727 |
29 | Premature rupture of membranes (HP:0001788) | 3.13851957 |
30 | Recurrent viral infections (HP:0004429) | 3.12750118 |
31 | Pustule (HP:0200039) | 3.08692843 |
32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.05772015 |
33 | Obstructive lung disease (HP:0006536) | 3.05772015 |
34 | Increased IgE level (HP:0003212) | 3.04735654 |
35 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.04456816 |
36 | Vacuolated lymphocytes (HP:0001922) | 2.95851249 |
37 | Myositis (HP:0100614) | 2.89221839 |
38 | Abnormality of T cells (HP:0002843) | 2.88577126 |
39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.87170633 |
40 | Recurrent skin infections (HP:0001581) | 2.85687400 |
41 | Axonal loss (HP:0003447) | 2.85022820 |
42 | Nail dystrophy (HP:0008404) | 2.83952315 |
43 | Increased serum pyruvate (HP:0003542) | 2.81877018 |
44 | Interstitial pulmonary disease (HP:0006530) | 2.81129052 |
45 | Pili torti (HP:0003777) | 2.79570637 |
46 | Autoimmune thrombocytopenia (HP:0001973) | 2.77801627 |
47 | Severe combined immunodeficiency (HP:0004430) | 2.74573232 |
48 | Mediastinal lymphadenopathy (HP:0100721) | 2.74386266 |
49 | Dysostosis multiplex (HP:0000943) | 2.67402554 |
50 | Abnormality of glycolysis (HP:0004366) | 2.66176068 |
51 | Combined immunodeficiency (HP:0005387) | 2.64329568 |
52 | Disinhibition (HP:0000734) | 2.63303639 |
53 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.60819958 |
54 | Alopecia of scalp (HP:0002293) | 2.58863823 |
55 | Osteolytic defects of the hand bones (HP:0009699) | 2.58647634 |
56 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.58647634 |
57 | Oral leukoplakia (HP:0002745) | 2.57096784 |
58 | Amniotic constriction ring (HP:0009775) | 2.54674545 |
59 | Abnormality of placental membranes (HP:0011409) | 2.54674545 |
60 | Leukocytosis (HP:0001974) | 2.50740988 |
61 | Palmoplantar hyperkeratosis (HP:0000972) | 2.47847432 |
62 | Acute necrotizing encephalopathy (HP:0006965) | 2.46740033 |
63 | Hypergammaglobulinemia (HP:0010702) | 2.46091520 |
64 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.45900358 |
65 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.45900358 |
66 | Abnormality of glycolipid metabolism (HP:0010969) | 2.45900358 |
67 | Trismus (HP:0000211) | 2.44642845 |
68 | Macrocytic anemia (HP:0001972) | 2.43762227 |
69 | Eosinophilia (HP:0001880) | 2.43347419 |
70 | Ridged nail (HP:0001807) | 2.39848279 |
71 | Pterygium (HP:0001059) | 2.39457409 |
72 | Palmar hyperkeratosis (HP:0010765) | 2.38910711 |
73 | Vertebral compression fractures (HP:0002953) | 2.37194822 |
74 | Deviation of the thumb (HP:0009603) | 2.36360579 |
75 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.35131936 |
76 | Autoimmune hemolytic anemia (HP:0001890) | 2.34971667 |
77 | Abnormality of eosinophils (HP:0001879) | 2.34818242 |
78 | Proximal placement of thumb (HP:0009623) | 2.33068214 |
79 | Hepatosplenomegaly (HP:0001433) | 2.33035681 |
80 | IgM deficiency (HP:0002850) | 2.32252544 |
81 | Rough bone trabeculation (HP:0100670) | 2.31751657 |
82 | Loss of speech (HP:0002371) | 2.30496302 |
83 | Thick nail (HP:0001805) | 2.30441555 |
84 | Spontaneous hematomas (HP:0007420) | 2.28899829 |
85 | Thyroiditis (HP:0100646) | 2.28351562 |
86 | Meningitis (HP:0001287) | 2.27326640 |
87 | Parakeratosis (HP:0001036) | 2.27267537 |
88 | Microvesicular hepatic steatosis (HP:0001414) | 2.26781819 |
89 | Aplasia cutis congenita (HP:0001057) | 2.23951402 |
90 | Vasculitis (HP:0002633) | 2.23634170 |
91 | Skin ulcer (HP:0200042) | 2.23593138 |
92 | Acute encephalopathy (HP:0006846) | 2.23004753 |
93 | Osteomyelitis (HP:0002754) | 2.22731737 |
94 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20410494 |
95 | Right ventricular cardiomyopathy (HP:0011663) | 2.20096388 |
96 | Sepsis (HP:0100806) | 2.19753891 |
97 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18803155 |
98 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18803155 |
99 | Woolly hair (HP:0002224) | 2.17520401 |
100 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.17079478 |
101 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.17079478 |
102 | Erythema (HP:0010783) | 2.16326293 |
103 | Breast hypoplasia (HP:0003187) | 2.14098261 |
104 | Ulnar claw (HP:0001178) | 2.13179758 |
105 | Multiple enchondromatosis (HP:0005701) | 2.12709322 |
106 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.12209057 |
107 | Neurofibrillary tangles (HP:0002185) | 2.11838846 |
108 | Onion bulb formation (HP:0003383) | 2.11314450 |
109 | Verrucae (HP:0200043) | 2.10992156 |
110 | Papilloma (HP:0012740) | 2.10992156 |
111 | Upper motor neuron abnormality (HP:0002127) | 2.10474968 |
112 | Bronchitis (HP:0012387) | 2.08887152 |
113 | Abnormal trabecular bone morphology (HP:0100671) | 2.08519002 |
114 | Cerebral edema (HP:0002181) | 2.07299216 |
115 | Achilles tendon contracture (HP:0001771) | 2.06826419 |
116 | Petechiae (HP:0000967) | 2.05350020 |
117 | Death in infancy (HP:0001522) | 2.05124198 |
118 | IgG deficiency (HP:0004315) | 2.04788221 |
119 | Cortical dysplasia (HP:0002539) | 2.03896064 |
120 | Hematochezia (HP:0002573) | 2.02776840 |
121 | Squamous cell carcinoma (HP:0002860) | 2.02690960 |
122 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.02251580 |
123 | Abnormal blistering of the skin (HP:0008066) | 2.01813820 |
124 | Natal tooth (HP:0000695) | 2.01414786 |
125 | Fragile skin (HP:0001030) | 1.99519371 |
126 | Chronic sinusitis (HP:0011109) | 1.99332442 |
127 | Gingivitis (HP:0000230) | 1.98942080 |
128 | Lymphopenia (HP:0001888) | 1.97941254 |
129 | Thoracolumbar scoliosis (HP:0002944) | 1.96614529 |
130 | Abnormal hair laboratory examination (HP:0003328) | 1.95378747 |
131 | Degeneration of anterior horn cells (HP:0002398) | 1.95079152 |
132 | Abnormality of the anterior horn cell (HP:0006802) | 1.95079152 |
133 | Granulocytopenia (HP:0001913) | 1.94509356 |
134 | Agammaglobulinemia (HP:0004432) | 1.93667459 |
135 | Abnormality of T cell physiology (HP:0011840) | 1.92203596 |
136 | Orchitis (HP:0100796) | 1.92164240 |
137 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.90546037 |
138 | Pallor (HP:0000980) | 1.90267991 |
139 | Insomnia (HP:0100785) | 1.89977026 |
140 | Short middle phalanx of the 5th finger (HP:0004220) | 1.89287034 |
141 | Basal ganglia calcification (HP:0002135) | 1.88483999 |
142 | Supranuclear gaze palsy (HP:0000605) | 1.88229976 |
143 | Ankyloglossia (HP:0010296) | 1.85694683 |
144 | Increased hepatocellular lipid droplets (HP:0006565) | 1.84957962 |
145 | Elbow flexion contracture (HP:0002987) | 1.84216072 |
146 | Slow saccadic eye movements (HP:0000514) | 1.83697935 |
147 | Tetraparesis (HP:0002273) | 1.83477369 |
148 | Fasciculations (HP:0002380) | 1.82854979 |
149 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82669963 |
150 | Mucopolysacchariduria (HP:0008155) | 1.82669963 |
151 | Lipid accumulation in hepatocytes (HP:0006561) | 1.81540073 |
152 | Abnormality of the umbilical cord (HP:0010881) | 1.81237253 |
153 | Progressive neurologic deterioration (HP:0002344) | 1.80014675 |
154 | Renal duplication (HP:0000075) | 1.79825271 |
155 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.78758285 |
156 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.78269776 |
157 | Spastic diplegia (HP:0001264) | 1.77460521 |
158 | Panhypogammaglobulinemia (HP:0003139) | 1.77401582 |
159 | Long palpebral fissure (HP:0000637) | 1.76585183 |
160 | Follicular hyperkeratosis (HP:0007502) | 1.75916687 |
161 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.75395158 |
162 | Abnormality of the lumbar spine (HP:0100712) | 1.75065064 |
163 | Episodic fever (HP:0001954) | 1.74927070 |
164 | Pseudobulbar signs (HP:0002200) | 1.74765880 |
165 | Optic neuritis (HP:0100653) | 1.73911984 |
166 | Retrobulbar optic neuritis (HP:0100654) | 1.73911984 |
167 | Insidious onset (HP:0003587) | 1.73847215 |
168 | Termporal pattern (HP:0011008) | 1.73847215 |
169 | Peripheral demyelination (HP:0011096) | 1.73759711 |
170 | Microretrognathia (HP:0000308) | 1.73753453 |
171 | Nausea (HP:0002018) | 1.72288085 |
172 | Hypotrichosis (HP:0001006) | 1.70408185 |
173 | Inflammation of the large intestine (HP:0002037) | 1.70109918 |
174 | Recurrent pneumonia (HP:0006532) | 1.70088954 |
175 | Overriding aorta (HP:0002623) | 1.69398137 |
176 | Increased CSF lactate (HP:0002490) | 1.68907096 |
177 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.68188696 |
178 | Increased CSF protein (HP:0002922) | 1.67878201 |
179 | Ankle contracture (HP:0006466) | 1.65227550 |
180 | Increased intramyocellular lipid droplets (HP:0012240) | 1.64108196 |
181 | Chromsome breakage (HP:0040012) | 1.62161027 |
182 | Absent eyelashes (HP:0000561) | 1.61860713 |
183 | Hypokinesia (HP:0002375) | 1.61718593 |
184 | Abnormality of oral frenula (HP:0000190) | 1.61346163 |
185 | Ragged-red muscle fibers (HP:0003200) | 1.60539715 |
186 | Mitochondrial inheritance (HP:0001427) | 1.60242446 |
187 | Abnormality of reticulocytes (HP:0004312) | 1.59485674 |
188 | Blepharitis (HP:0000498) | 1.59117789 |
189 | Upper limb muscle weakness (HP:0003484) | 1.58239404 |
190 | Horseshoe kidney (HP:0000085) | 1.58044158 |
191 | Erythroderma (HP:0001019) | 1.57719140 |
192 | Dysphonia (HP:0001618) | 1.56773055 |
193 | Progressive muscle weakness (HP:0003323) | 1.55716833 |
194 | Back pain (HP:0003418) | 1.53394040 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.80757202 |
2 | TESK2 | 2.97696022 |
3 | BLK | 2.93651693 |
4 | STK10 | 2.91912061 |
5 | EPHB1 | 2.89923965 |
6 | ARAF | 2.70195583 |
7 | NEK1 | 2.58649474 |
8 | TXK | 2.54207259 |
9 | CDC7 | 2.50455799 |
10 | TYK2 | 2.42813103 |
11 | TTK | 2.38319658 |
12 | SRPK1 | 2.34729774 |
13 | MST4 | 2.33978983 |
14 | JAK3 | 2.25383525 |
15 | ITK | 2.18138375 |
16 | ZAP70 | 2.16058966 |
17 | NME2 | 2.13577939 |
18 | EIF2AK1 | 2.09439382 |
19 | EPHB2 | 2.07027192 |
20 | MAPKAPK5 | 2.04773984 |
21 | TBK1 | 2.03643248 |
22 | IRAK3 | 2.00927726 |
23 | TESK1 | 1.99169827 |
24 | LATS2 | 1.98173307 |
25 | TIE1 | 1.97194507 |
26 | PBK | 1.91196414 |
27 | PAK4 | 1.86030157 |
28 | RIPK4 | 1.85860167 |
29 | TSSK6 | 1.83932098 |
30 | BRAF | 1.82461969 |
31 | LIMK1 | 1.81948629 |
32 | IKBKE | 1.80649843 |
33 | MARK3 | 1.77355982 |
34 | PLK4 | 1.75030721 |
35 | WEE1 | 1.74790956 |
36 | LRRK2 | 1.74703943 |
37 | EPHA2 | 1.72226619 |
38 | VRK2 | 1.69447377 |
39 | KDR | 1.67492122 |
40 | NLK | 1.66967267 |
41 | STK16 | 1.65615528 |
42 | STK39 | 1.61054952 |
43 | PIM2 | 1.59258738 |
44 | FGFR4 | 1.57154579 |
45 | ABL2 | 1.51384917 |
46 | LCK | 1.50027731 |
47 | JAK1 | 1.43192813 |
48 | MAP3K14 | 1.42156750 |
49 | KIT | 1.38756228 |
50 | NTRK1 | 1.33133800 |
51 | RPS6KA4 | 1.31471635 |
52 | TEC | 1.29134455 |
53 | CLK1 | 1.27859196 |
54 | MAP3K10 | 1.27716455 |
55 | TRPM7 | 1.25233342 |
56 | PLK1 | 1.20341386 |
57 | HCK | 1.17342934 |
58 | BTK | 1.15472731 |
59 | PTK2 | 1.15468264 |
60 | SMG1 | 1.14214670 |
61 | ERBB4 | 1.13756884 |
62 | MKNK1 | 1.11791750 |
63 | SYK | 1.11204116 |
64 | CSK | 1.10992929 |
65 | IRAK4 | 1.10599499 |
66 | DYRK3 | 1.10430280 |
67 | DDR2 | 1.08290763 |
68 | TGFBR2 | 1.07539546 |
69 | EPHA3 | 1.01871985 |
70 | CHEK2 | 1.00450722 |
71 | BCKDK | 1.00419481 |
72 | PLK3 | 0.99938551 |
73 | FGFR2 | 0.99906234 |
74 | EEF2K | 0.99479421 |
75 | TGFBR1 | 0.99089968 |
76 | AURKA | 0.97325029 |
77 | FGFR3 | 0.96054495 |
78 | IRAK1 | 0.93476148 |
79 | IKBKB | 0.93175070 |
80 | AURKB | 0.91468101 |
81 | BRSK1 | 0.85776005 |
82 | KSR2 | 0.85007931 |
83 | MAP3K12 | 0.83722855 |
84 | ERN1 | 0.83603569 |
85 | PRKG2 | 0.83500825 |
86 | GRK6 | 0.79399414 |
87 | CDK7 | 0.79120236 |
88 | JAK2 | 0.78804712 |
89 | PIM1 | 0.77156585 |
90 | TAOK2 | 0.76563371 |
91 | CDK14 | 0.75443184 |
92 | PNCK | 0.73258793 |
93 | SCYL2 | 0.73003479 |
94 | MAP3K3 | 0.71879761 |
95 | PDK2 | 0.71791740 |
96 | MAPKAPK3 | 0.68656379 |
97 | CSF1R | 0.68626289 |
98 | LYN | 0.68232925 |
99 | CDK11A | 0.68055555 |
100 | CHEK1 | 0.67249001 |
101 | MST1R | 0.67159775 |
102 | BUB1 | 0.66902373 |
103 | BCR | 0.66344373 |
104 | MAP3K13 | 0.65446395 |
105 | DMPK | 0.65370863 |
106 | MAP3K11 | 0.64536932 |
107 | TRIB3 | 0.63628949 |
108 | STK24 | 0.63138499 |
109 | CDK15 | 0.63067993 |
110 | PRKCQ | 0.62989647 |
111 | CDK18 | 0.62068561 |
112 | TAF1 | 0.61878552 |
113 | HIPK2 | 0.60758653 |
114 | MAP3K8 | 0.60494452 |
115 | PDGFRA | 0.60080277 |
116 | RAF1 | 0.59776645 |
117 | MAPKAPK2 | 0.59330782 |
118 | CSNK2A1 | 0.58325594 |
119 | ATR | 0.57073195 |
120 | CDK19 | 0.56905661 |
121 | STK4 | 0.55993837 |
122 | CDK8 | 0.54251966 |
123 | PRKCH | 0.54004151 |
124 | FES | 0.53813110 |
125 | PDK1 | 0.53418053 |
126 | CSNK1G1 | 0.52657787 |
127 | MAP2K2 | 0.51754735 |
128 | DYRK2 | 0.51552164 |
129 | TRIM28 | 0.51277868 |
130 | CSNK2A2 | 0.50946851 |
131 | RPS6KA5 | 0.50356701 |
132 | CSNK1G2 | 0.49987769 |
133 | IRAK2 | 0.49138504 |
134 | MAP2K3 | 0.48463445 |
135 | FLT3 | 0.47961642 |
136 | MAP3K2 | 0.47956550 |
137 | PLK2 | 0.47829221 |
138 | MAP3K9 | 0.47214615 |
139 | GRK7 | 0.46769532 |
140 | PAK2 | 0.46132809 |
141 | MAP3K1 | 0.45296545 |
142 | CSNK1A1L | 0.43844944 |
143 | PDGFRB | 0.43106114 |
144 | PRKD1 | 0.42248896 |
145 | ALK | 0.41801049 |
146 | CSNK1G3 | 0.41391485 |
147 | MATK | 0.41259960 |
148 | NEK2 | 0.41148830 |
149 | MET | 0.40698190 |
150 | ABL1 | 0.39629386 |
151 | EIF2AK2 | 0.39025460 |
152 | CSNK1E | 0.37627633 |
153 | PTK6 | 0.36386145 |
154 | MAPK4 | 0.35885305 |
155 | FYN | 0.35385580 |
156 | EGFR | 0.34835034 |
157 | OXSR1 | 0.34420658 |
158 | RET | 0.33718831 |
159 | MOS | 0.33001158 |
160 | CDK6 | 0.32669290 |
161 | PRKCI | 0.32614831 |
162 | PAK1 | 0.31918333 |
163 | EIF2AK3 | 0.31734401 |
164 | RIPK1 | 0.31676404 |
165 | CDK9 | 0.31122852 |
166 | BMX | 0.30642123 |
167 | BRSK2 | 0.30566559 |
168 | PRKCD | 0.29571518 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.85727463 |
2 | Mismatch repair_Homo sapiens_hsa03430 | 2.70219116 |
3 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.67316426 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34851216 |
5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.29365453 |
6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.18085557 |
7 | Spliceosome_Homo sapiens_hsa03040 | 2.17037431 |
8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16665517 |
9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.07280472 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.03700037 |
11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.94973275 |
12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.94247605 |
13 | Measles_Homo sapiens_hsa05162 | 1.93438139 |
14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.93234539 |
15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.89139640 |
16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.82356715 |
17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82343262 |
18 | RNA transport_Homo sapiens_hsa03013 | 1.81544727 |
19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81074679 |
20 | Base excision repair_Homo sapiens_hsa03410 | 1.81065340 |
21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.76943959 |
22 | Lysosome_Homo sapiens_hsa04142 | 1.72939410 |
23 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.72500230 |
24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71645796 |
25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.71487674 |
26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70386689 |
27 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.68783893 |
28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.68459092 |
29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.65278384 |
30 | Shigellosis_Homo sapiens_hsa05131 | 1.63222238 |
31 | RNA polymerase_Homo sapiens_hsa03020 | 1.62859328 |
32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.62844133 |
33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.57753216 |
34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.57203858 |
35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.54559265 |
36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52669889 |
37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.51570273 |
38 | Pertussis_Homo sapiens_hsa05133 | 1.48845437 |
39 | Bladder cancer_Homo sapiens_hsa05219 | 1.48020582 |
40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47105826 |
41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46840949 |
42 | Salmonella infection_Homo sapiens_hsa05132 | 1.46102435 |
43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.45193596 |
44 | Allograft rejection_Homo sapiens_hsa05330 | 1.45163312 |
45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.44470901 |
46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44000048 |
47 | Huntingtons disease_Homo sapiens_hsa05016 | 1.42487006 |
48 | Malaria_Homo sapiens_hsa05144 | 1.41848949 |
49 | Legionellosis_Homo sapiens_hsa05134 | 1.41840442 |
50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.41788490 |
51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.41544259 |
52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40837778 |
53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.40804627 |
54 | Tuberculosis_Homo sapiens_hsa05152 | 1.38284638 |
55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.38021410 |
56 | Sulfur relay system_Homo sapiens_hsa04122 | 1.37655585 |
57 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37429192 |
58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36955469 |
59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35186577 |
60 | Ribosome_Homo sapiens_hsa03010 | 1.33975364 |
61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32259472 |
62 | Alzheimers disease_Homo sapiens_hsa05010 | 1.32023463 |
63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31734234 |
64 | Homologous recombination_Homo sapiens_hsa03440 | 1.29928684 |
65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28130917 |
66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.28020275 |
67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27025718 |
68 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.26693439 |
69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24178438 |
70 | Apoptosis_Homo sapiens_hsa04210 | 1.23800568 |
71 | Phagosome_Homo sapiens_hsa04145 | 1.23154686 |
72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18605674 |
73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.18057296 |
74 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17064223 |
75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13987831 |
76 | Hepatitis B_Homo sapiens_hsa05161 | 1.12624660 |
77 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10855456 |
78 | Influenza A_Homo sapiens_hsa05164 | 1.10796065 |
79 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10703071 |
80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10050642 |
81 | Platelet activation_Homo sapiens_hsa04611 | 1.09173839 |
82 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08767153 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07882639 |
84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06905595 |
85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05884094 |
86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.05647922 |
87 | Asthma_Homo sapiens_hsa05310 | 1.04633913 |
88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.03874004 |
89 | Endocytosis_Homo sapiens_hsa04144 | 1.03724377 |
90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.02055913 |
91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01758736 |
92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00526604 |
93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00358133 |
94 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00232998 |
95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00219614 |
96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95955877 |
97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95752555 |
98 | DNA replication_Homo sapiens_hsa03030 | 0.94091269 |
99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91309386 |
100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88124383 |
101 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.85650548 |
102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85443380 |
103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85107758 |
104 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.85008633 |
105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.83698852 |
106 | Hepatitis C_Homo sapiens_hsa05160 | 0.83686233 |
107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82086613 |
108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81161168 |
109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80404235 |
110 | Prion diseases_Homo sapiens_hsa05020 | 0.80350615 |
111 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.79939749 |
112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78439397 |
113 | RNA degradation_Homo sapiens_hsa03018 | 0.78350578 |
114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77193555 |
115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76698042 |
116 | Purine metabolism_Homo sapiens_hsa00230 | 0.76270860 |
117 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75206339 |
118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72538895 |
119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71557805 |
120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71150368 |
121 | Amoebiasis_Homo sapiens_hsa05146 | 0.70803928 |
122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69344629 |
123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67432806 |
124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66870630 |
125 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66312427 |
126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66284984 |
127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65478397 |
128 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61791349 |
129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61273123 |
130 | Proteasome_Homo sapiens_hsa03050 | 0.60995963 |
131 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60447198 |
132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58286521 |
133 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57786205 |
134 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56746563 |
135 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54533711 |
136 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.53457835 |
137 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52145652 |
138 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52075928 |
139 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.50972757 |
140 | Prostate cancer_Homo sapiens_hsa05215 | 0.48764574 |
141 | Protein export_Homo sapiens_hsa03060 | 0.48418128 |
142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48289769 |
143 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46699257 |
144 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46058210 |
145 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45766543 |
146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45704963 |
147 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45644051 |
148 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45173978 |
149 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.45063695 |
150 | * Mineral absorption_Homo sapiens_hsa04978 | 0.44884711 |
151 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44363051 |
152 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43694161 |
153 | Adherens junction_Homo sapiens_hsa04520 | 0.43160316 |
154 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43026760 |
155 | Cell cycle_Homo sapiens_hsa04110 | 0.43002229 |
156 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42802403 |
157 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42427957 |
158 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.42390916 |
159 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41507132 |
160 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.41498086 |
161 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40521332 |
162 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39422594 |
163 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38921487 |
164 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38863673 |
165 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38183084 |
166 | Focal adhesion_Homo sapiens_hsa04510 | 0.37861693 |
167 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37831893 |
168 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35455696 |
169 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.33621445 |
170 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30952169 |
171 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27562346 |
172 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26246809 |
173 | Melanoma_Homo sapiens_hsa05218 | 0.23888346 |